Middle East & Africa Manufacturing Execution System (MES) In Life Sciences Market

The Middle East & Africa manufacturing execution system in life sciences market is expected to grow from US$ 231.17 million in 2023 to US$ 609.93 million by 2033. It is estimated to grow at a CAGR of 10.2% from 2023 to 2033.   

Shift from Legacy to Modern MES Fuels Middle East & Africa Manufacturing Execution System (MES) In Life Sciences Market

Modern MES solution is an advanced and lighter version of MES. It helps enhance pharmaceutical industry production processes without requiring custom coding. The digital production records and automated workflows that foster right-first-time batches provided by the modern MES will further help increase efficiency. In addition, the fast and flexible responsiveness of the modern MES solution will make it easier to change production lines and accommodate small batches. The solution provides real-time visibility by helping retrieve data from local and remote locations. Thus, various pharma companies are shifting to modern MES solutions to develop high-quality pharmaceutical products and enhance production performance. Some examples of modern MES solutions are Tulip’s Next Gen MES, MasterControl’s MES, 42Q’s MES 101, and EIS’s OpsTrakker Solution Suite, among others. Bristol-Myers Squibb, Synthego Corporation, Sri Krishna Pharmaceuticals Limited, EpiBone, and Fagron NV are among the users of these modern MES solutions. Such factors are expected to promote the adoption of modern manufacturing execution systems among life sciences players during the forecast period.

Middle East & Africa Manufacturing Execution System (MES) In Life Sciences Market Overview

Middle East, Saudi Arabia is the largest pharmaceutical manufacturing market, which accounts for 60% of the regional share, followed by the UAE. The largest part of the Saudi manufacturing industry is spread in the Gulf region, however, most of the local production is destined for export markets. Leading indigenous players in the region include Spimaco, Jamjoom Pharma, Tabuk Pharmaceutical Manufacturing, Jazeera Pharmaceutical Industries, and Julphar. Top multinational companies such as GSK, Sanofi, and Abbott Laboratories have also set up manufacturing units in the region. Per the Saudi Vision 2030, the country is a unique transformative economic and social reform blueprint. With this vision, it is opening up to the world and looking for the upgrading of its healthcare sector. The progressive healthcare and life sciences sector would bring huge growth avenues to the MES in life sciences market during the forecast period.

Middle East & Africa Manufacturing Execution System (MES) In Life Sciences Market Revenue and Forecast to 2033 (US$ Million)

Middle East & Africa Manufacturing Execution System (MES) In Life Sciences Strategic Insights

Strategic insights for the Middle East & Africa Manufacturing Execution System (MES) In Life Sciences provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Middle East & Africa Manufacturing Execution System (MES) In Life Sciences Report Scope

Middle East & Africa Manufacturing Execution System (MES) In Life Sciences Regional Insights

The geographic scope of the Middle East & Africa Manufacturing Execution System (MES) In Life Sciences refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Middle East & Africa Manufacturing Execution System (MES) In Life Sciences Market Segmentation

The Middle East & Africa manufacturing execution system in life sciences market is segmented into offering, deployment, organization size, application, and country.

Based on offering, the Middle East & Africa manufacturing execution system in life sciences market is segmented into software and services. The services segment held a larger share of the Middle East & Africa manufacturing execution system in life sciences market in 2023.

Based on deployment, the Middle East & Africa manufacturing execution system in life sciences market is segmented into on-premises and cloud. The cloud segment held a larger share of the Middle East & Africa manufacturing execution system in life sciences market in 2023.

Based on organization size, the Middle East & Africa manufacturing execution system in life sciences market is segmented into SMEs and large enterprises. The large enterprises segment held the largest share of the Middle East & Africa manufacturing execution system in life sciences market in 2023.

Based on application, the Middle East & Africa manufacturing execution system in life sciences market is segmented into pharmaceutical, biotechnology, and medical devices. The medical devices segment held the largest share of the Middle East & Africa manufacturing execution system in life sciences market in 2023.

Based on country, the Middle East & Africa manufacturing execution system in life sciences market is segmented into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. The UAE dominated the share of the Middle East & Africa manufacturing execution system in life sciences market in 2023.

ATS Global B.V.; Emerson Electric Co; Rockwell Automation Inc; Schneider Electric SE; and Siemens AG are the leading companies operating in the Middle East & Africa manufacturing execution system in life sciences market.